NCT06526884

Brief Summary

The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions \[UVAS\] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,080

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

July 22, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 30, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 18, 2026

Status Verified

January 1, 2026

Enrollment Period

1.5 years

First QC Date

July 17, 2024

Last Update Submit

March 16, 2026

Conditions

Keywords

Patient safetyCost effectivenessAvoidable hospitalizations

Outcome Measures

Primary Outcomes (1)

  • Days alive and out of hospital (DAOH)

    Cumulative number of days alive and not admitted or boarding in a hospital or emergency department

    30 days from index ED visit

Secondary Outcomes (6)

  • Global health-related quality of life

    30 days from index ED visit

  • Patient experience

    30 days from index ED visit

  • Financial analysis

    Through study completion, an average of 12 months

  • Cost effectiveness analysis

    Through study completion, an average of 12 months

  • Hospitalizations avoided

    Through study completion, an average of 12 months

  • +1 more secondary outcomes

Study Arms (2)

ED-initiated hospitalization

NO INTERVENTION

Patients with odd birthdays will be routed to standard-of-care ED-initiated hospitalization pathways.

Next Day Clinic

EXPERIMENTAL

Patients with even birthdays who meet inclusion criteria will be given the option to receive care in the Next Day Clinic to avoid hospitalization.

Other: Next Day Clinic

Interventions

A dedicated Next Day Clinic team consisting of a clinician and nurse case manager will provide care and specialist referrals to patients within 24 hours of an ED visit that would have resulted in hospitalization without this novel hospital avoidance initiative.

Next Day Clinic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • About to be admitted through the ED for one of the NDC diagnoses or a synonym (per Study Protocol document), defined by the presence of a Plan to Admit order or Bed Request order, OR recently admitted under observation or inpatient status for one of the NDC diagnoses.
  • Identified as at-risk for an avoidable hospitalization in the ED based on a pre-determined set of lab and vital parameters.
  • Insurance that authorizes the patient to follow-up at UCLA Health, or self-pay
  • Admitted or being admitted to an internal medicine service

You may not qualify if:

  • Heart or lung transplant recipient with concern for graft dysfunction
  • Pregnant
  • Enrolled in hospice
  • Admitted to a critical care service
  • ED deems discharge unsafe due to complex social or medical factors
  • Active malignant cancer (per Council of State and Territorial Epidemiologists value set)
  • Pulmonary arterial hypertension (per Joint Commission value set)
  • Undergoing workup for solid organ transplant
  • Interstitial lung disease (including pulmonary fibrosis) (per Higher Level 7 value set)
  • Requiring inpatient procedure or surgery defined by the presence of an anesthesia event or operating room encounter.
  • The ED deems discharge unsafe due to complex social or medical factors.
  • Transferred to an ineligible hospital
  • Note:
  • The Health System plans to limit the volume of referrals to the NDC by only referring patients who have an even birth date (this is more equitable than first-come-first-serve, because wage workers are more likely to come to the ED later in the day; even/odd birth date theoretically keeps more spots open for patients presenting to the ED later).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ronald Reagan UCLA Medical Center

Los Angeles, California, 90024, United States

Location

MeSH Terms

Conditions

PneumoniaSyncopeHeart FailureCellulitisPyelonephritisAcute Kidney InjuryOsteomyelitis

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsHeart DiseasesCardiovascular DiseasesSkin Diseases, InfectiousSuppurationConnective Tissue DiseasesSkin and Connective Tissue DiseasesInflammationPathologic ProcessesNephritis, InterstitialNephritisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPyelitisMale Urogenital DiseasesRenal InsufficiencyBone Diseases, InfectiousBone DiseasesMusculoskeletal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomized encouragement trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 17, 2024

First Posted

July 30, 2024

Study Start

July 22, 2024

Primary Completion

January 20, 2026

Study Completion

April 1, 2026

Last Updated

March 18, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

De-identified data may be uploaded to a data repository system such as Vivli.

Locations